Growing Market Presence Cirdan has expanded its global footprint with installations in over 72 laboratories across six continents, indicating a strong international reach and potential for further deployment in emerging markets seeking advanced pathology solutions.

Recent Product Acquisition The acquisition of ULTRA LIS from GE Healthcare positions Cirdan as a key player in laboratory information systems, creating opportunities to upsell, integrate, or customize these solutions for labs seeking to enhance diagnostic workflows.

Strategic Investment Receiving a $9.8 million investment from the British Business Bank signals strong growth potential and financial backing, making Cirdan an attractive partner for expansion and large-scale deployment projects in healthcare diagnostics.

Industry Focus Specializing in pathology and clinical laboratory imaging and software solutions, Cirdan offers targeted technologies that can complement existing laboratory infrastructure, ideal for labs seeking to modernize or upgrade their diagnostic capabilities.

Innovation and Networking Organizing Pathology Horizons and engaging in industry conferences builds Cirdan’s reputation and opens networking channels with healthcare providers, enabling direct engagement and customized sales approaches to prospective clients.